Loading...
Guest User
Welcome! Please login.
* - Tentative Dates
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Funding working capital requirements of the Company | 1.27 |
| 2 | Adjustment of unsecured loans against the entitlement of Promoter | 1.11 |
| 3 | Repayment / Settlement of Certain Outstanding Borrowings | 0.65 |
| 4 | General corporate purpose | 1.08 |
| Period Ended | 31 Mar 2025 | 31 Mar 2024 |
|---|---|---|
| Total Income | 4.46 | 5.05 |
| Profit After Tax | 0.40 | 0.62 |
| NET Worth | 9.96 | 9.54 |
| Reserves and Surplus | 5.62 | 5.21 |
| Amount in ₹ Crore | ||
Dr Lalchandani Labs Limited is a diagnostics-focused healthcare company headquartered in New Delhi, delivering a wide range of pathology and medical testing services across the Delhi and NCR region through its network of laboratories and sample collection centers.
The company offers an extensive diagnostic portfolio covering biochemistry, hematology, microbiology, virology, genetic and molecular testing, preventive health check-ups, corporate wellness programs, and blood bank services. Its operations are centered on accuracy, quality assurance, and timely reporting of test results.
Built on the foundation of a long-standing pathology practice, Dr Lalchandani Labs operates NABL-accredited facilities equipped with modern diagnostic infrastructure. The company caters to individual patients as well as hospitals, clinics, and healthcare institutions, supported by multiple strategically located collection centers.
